It can be concluded that EAM-2201 has the potential to result in in vivo pharmacokinetic drug interactions when co-administered with substrates of CYP2C8, CYP3A4 and UGT1A3, and is also evaluated in pooled human liver microsomes. Probable metabolites from the cannabimimetic agent JWH-018 have been synthesised, characterised to probe for their https://marvinp383wma6.wikiusnews.com/user